Stocks · News reference

JP Morgan Maintains Overweight on Edwards Lifesciences, Raises Price Target to $105

Jul 24, 2026, 5:46 PMBenzinga Newsdesk

JP Morgan analyst Robbie Marcus maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $100 to $105.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaJul 24, 2026, 4:37 PMBenzinga Newsdesk
Piper Sandler Reiterates Overweight on Edwards Lifesciences, Raises Price Target to $101
Piper Sandler analyst Adam Maeder reiterates Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $100 to $101.
Read original at benzinga
EW
BenzingaJul 24, 2026, 3:48 PMVandana Singh
Edwards Earnings Add Fuel To Bullish MedTech Thesis, Analyst Says
Edwards Lifesciences tops Q2 Wall Street estimates with $1.74B in revenue. EW stock jumps as analysts see continued upside ahead.
Read original at benzinga
EW
BenzingaJul 24, 2026, 11:44 AMBenzinga Newsdesk
Edwards Lifesciences shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance.
Read original at benzinga
EW